Administration of i.v. medications in the NICU: the development of a procedure.
Hargrove
C
C
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous / Q000379:methods; D007363:Intensive Care Units, Neonatal; D012307:Risk Factors
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents